Covalon Technologies (OTCMKTS:CVALF - Get Free Report) is expected to announce its earnings results before the market opens on Tuesday, May 27th. Analysts expect the company to announce earnings of $0.01 per share and revenue of $7.67 million for the quarter.
Covalon Technologies (OTCMKTS:CVALF - Get Free Report) last announced its quarterly earnings data on Friday, February 21st. The company reported $0.03 EPS for the quarter, beating the consensus estimate of ($0.03) by $0.06. Covalon Technologies had a net margin of 8.58% and a return on equity of 12.33%. The business had revenue of $5.84 million during the quarter, compared to the consensus estimate of $6.37 million.
Covalon Technologies Stock Up 2.2%
Shares of Covalon Technologies stock opened at $1.86 on Tuesday. Covalon Technologies has a twelve month low of $0.77 and a twelve month high of $3.08. The stock has a market cap of $51.00 million, a price-to-earnings ratio of 26.58 and a beta of 0.49. The company's fifty day moving average is $1.69 and its 200 day moving average is $2.08.
Covalon Technologies Company Profile
(
Get Free Report)
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Covalon Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Covalon Technologies wasn't on the list.
While Covalon Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
